Literature DB >> 9429289

Isolation and evaluation of susceptibility to sulphasalazine of Desulfovibrio desulfuricans strains from the human digestive tract.

Z Dzierzewicz1, B Cwalina, B Gawlik, T Wilczok, Z Gonciarz.   

Abstract

Various genera of sulphate reducing bacteria (SRB) have been found in the human digestive tract. It is suggested that some of SRB species may be responsible for the development of the clinical symptoms of ulcerative colitis and other disease of large intestine. Sulphasalazine (salicyl-azo-sulphapyridine, SAS) is commonly used to treat patients with ulcerative colitis and Crohn disease. Above 30 samples of faeces or biopsy specimens from 25 patients (age 45 +/- 14 years; M/F, 13/12) suffering from gastrointestinal disorders were used for isolation of Desulfovibrio desulfuricans species. The morphological, physiological and biochemical characteristics of isolated strains and also their susceptibility to SAS was determined. D. desulfuricans isolates were obtained from 5 amongst all patients assayed. Some abnormal, cigar-shaped cells were detected as accompanying the cells represented by rods, curved rods and vibrios. After strains purification, two types of colonies were present on the solid Postgate's medium B (containing lactate as a carbon source and sulphate for energy conservation): the black colonies growing in bulk of agar medium and the transparent, surface-growing mucous colonies. These two types of D. desulfuricans colonies may be a result of different iron availability for bacterial cells. High metabolic activity of strain was not always accompanied by the presence of H2S gas lock in the test tube, although the H2S odor was perceptible. All tested strains multiplied inconsiderably slowly in the presence of SAS at concentrations 10, 20, 40 and 60 mg/cm3. The growing concentrations of SAS did not cause a proportional decrease of the bacterial cells number. Taking into account the positive results of using SAS to treat patients with some colonic diseases and the indicated resistance to SAS of intestinal D. desulfuricans strains, it appears probable, that this SRB species isn't responsible for the development of mentioned diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9429289

Source DB:  PubMed          Journal:  Acta Microbiol Pol        ISSN: 0137-1320


  7 in total

1.  Desulfovibrio desulfuricans bacteremia in a dog.

Authors:  S K Shukla; K D Reed
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera.

Authors:  Yumi A Warren; Diane M Citron; C Vreni Merriam; Ellie J C Goldstein
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Quantitative evaluation of transcriptional activation of NF-κB p65 and p50 subunits and IκBα encoding genes in colon cancer cells by Desulfovibrio desulfuricans endotoxin.

Authors:  M Kapral; L Węglarz; B Parfiniewicz; J Lodowska; M Jaworska-Kik
Journal:  Folia Microbiol (Praha)       Date:  2011-01-21       Impact factor: 2.099

4.  Antagonistic activity of Bacillus sp. obtained from an Algerian oilfield and chemical biocide THPS against sulfate-reducing bacteria consortium inducing corrosion in the oil industry.

Authors:  Mohamed Lamine Gana; Salima Kebbouche-Gana; Abdelkader Touzi; Mohamed Amine Zorgani; André Pauss; Hakim Lounici; Nabil Mameri
Journal:  J Ind Microbiol Biotechnol       Date:  2010-10-15       Impact factor: 3.346

5.  Phytic acid modulates in vitro IL-8 and IL-6 release from colonic epithelial cells stimulated with LPS and IL-1beta.

Authors:  Ludmiła Weglarz; Joanna Wawszczyk; Arkadiusz Orchel; Marzena Jaworska-Kik; Zofia Dzierzewicz
Journal:  Dig Dis Sci       Date:  2006-12-12       Impact factor: 3.487

6.  Initial stage of the biofilm formation on the NiTi and Ti6Al4V surface by the sulphur-oxidizing bacteria and sulphate-reducing bacteria.

Authors:  Beata Cwalina; Weronika Dec; Joanna K Michalska; Marzena Jaworska-Kik; Sebastian Student
Journal:  J Mater Sci Mater Med       Date:  2017-09-27       Impact factor: 3.896

7.  Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.

Authors:  Ying Hong; Lili Sheng; Jing Zhong; Xin Tao; Weize Zhu; Junli Ma; Juan Yan; Aihua Zhao; Xiaojiao Zheng; Gaosong Wu; Bingbing Li; Bangxing Han; Kan Ding; Ningning Zheng; Wei Jia; Houkai Li
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.